Invention Grant
- Patent Title: Meningococcal B recombinant vaccine
-
Application No.: US17674932Application Date: 2022-02-18
-
Publication No.: US12053516B2Publication Date: 2024-08-06
- Inventor: Nadège Arnaud-Barbe , Vinod Balhara , Raffaella Iantomasi , Marie-Pierre Kazek-Duret , Jacqueline McCluskey , Laurence Quemeneur , Bachra Rokbi , John Shiver
- Applicant: SANOFI PASTEUR INC.
- Applicant Address: US MA Cambridge
- Assignee: SANOFI PASTEUR INC.
- Current Assignee: SANOFI PASTEUR INC.
- Current Assignee Address: US PA Swiftwater
- Agency: LATHROP GPM LLP
- Agent James H. Velema, Esq.
- Priority: EP 305211 2021.02.19
- Main IPC: A61K39/095
- IPC: A61K39/095 ; A61K39/00 ; A61K39/39 ; A61P31/04 ; A61P37/04

Abstract:
The present disclosure relates to an immunogenic composition comprising a combination of meningococcal antigens which comprises at least one factor H binding protein (fHBP) A protein, at least one fHBP B protein, at least one Neisseria adhesin A (NadA) protein, and at least one detergent-extracted Outer Membrane Vesicle (dOMV). The meningococcal antigens may be from a Neisseria meningitidis serogroup B. The combination of antigens provided a broad coverage of bacteria strains. Further, the present disclosure relates to the use of the immunogenic composition in methods for eliciting an immune response.
Public/Granted literature
- US20220265805A1 MENINGOCOCCAL B RECOMBINANT VACCINE Public/Granted day:2022-08-25
Information query